The steps of the cancer-immunity cycle were assessed using eight axes of the immunogram score (IGS), which included T cell immunity (IGS1), tumor antigenicity (IGS2), priming and activation (IGS3), trafficking and infiltration (IGS4), recognition of tumor cells (IGS5), inhibitor cells (IGS6), checkpoint expression (IGS7), and inhibitory molecules (IGS8). This evidence concerns the gene AMN and neoplasm.